Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Stephen Strickland

3 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Diagnostic

ECOGHEMEAI141

05/10/2016

Early Assessment of Treatment Response in AML Using FLT PET/CT Imaging

Treatment

VICCHEM1553

03/10/2016

Phase II Trial of Vosaroxin in Combination with Infusional Cytarabine in Patients with Untreated AML

Treatment

VICCHEM1597

02/17/2016

A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation